A panelist discusses how uncomplicated urinary tract infections (UTIs) typically affect otherwise healthy individuals and can be treated with short-course antibiotics by primary care physicians, while complicated UTIs involve underlying conditions or anatomical abnormalities requiring specialized care from urologists, infectious disease specialists, and other healthcare providers working collaboratively to optimize treatment outcomes through coordinated multidisciplinary management.
Video content above is prompted by the following:
BeiGene’s Mehrdad Mobasher, MD, MPH, Discusses CLL Data, Pipeline Following ASH 2024
January 2nd 2025This interview will appear in the January 2025 issue of Evidence-Based Oncology, our annual recap of the American Society of Hematology Meeting and Exposition. After this article went to press, the company announced its ticker symbol on the Nasdaq will change today.
Read More